Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prescreening Study to Identify Potential Participants With ABCA4-related Retinopathy for ACDN-01 Clinical Trials

NCT06445322 is registered in ClinicalTrials.gov with Ascidian Therapeutics, Inc as lead sponsor.

NCT NCT06445322
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06445322 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prescreening Study to Identify Potential Participants With ABCA4-related Retinopathy for ACDN-01 Clinical Trials
Lead sponsor
Ascidian Therapeutics, Inc
Phase
Observational
Overall status
Recruiting
Start date
June 20, 2024
Completion date
August 31, 2030
Enrollment
50 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

cone rod dystrophy, juvenile macular degeneration, stargardt disease, stargardt disease 1